Cancer research firm's expansion to bring 200 jobs to Wake County

 A company researching ways to use gene editing to treat cancer is bringing 200 high-paying jobs to Wake County by 2023. French biotech Cellectis has picked an existing facility in Raleigh over a competing site in Monmouth Junction, New Jersey. New Jersey had offered more than $8 million in a c ompeting incentives package to land Cellectis' first North American immunotherapy manufacturing facility. . North Carolina's winning offer came to more than $2 million for the company. The City of Raleigh…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news